![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
. | ![]() |
. |
![]() By Mihaela RODINA, Ionut IORDACHESCU with Diana SIMEONOVA in Sofia Bucharest (AFP) Sept 29, 2021
In a Bucharest back street, drug addicts rush towards an ambulance handing out free syringes. While the eyes of the world focus on the Covid-19 pandemic, the fight against HIV has slowed down in Eastern Europe. Three times a week, Alina Schiau and colleagues from the Romanian anti-AIDS Association (ARAS) go out to the rougher parts of the city to hand out syringes and bandages to injecting drug users, and condoms to sex workers. But their funds are running low and stocks dwindling. Come November, their ambulance might have to stay in the garage. "What's cheaper? To buy a syringe and thus focus on prevention? Or to treat a patient for years?" says social worker Ada Luca, indignant at government inaction. Bulgaria and Romania are both former Eastern bloc countries, and in 2019, 76 percent of AIDS cases diagnosed in Europe were in the East, according to the European Centre for Disease Prevention and Control (ECDC). "It is obvious that the number of contaminations has increased since the start of the pandemic", Schiau told AFP. As coronavirus took hold, hospitals closed to non-Covid patients, says Davron Mukhamadiev, Regional Health and Care Coordinator for Red Cross Europe (IFRC). Quarantine requirements, travel restrictions and reduced access to rapid testing and diagnostic services all undermined efforts to roll back HIV/AIDS, he said. - 'We are abandoned' - UNAIDS data shows 140,000 new infections in Eastern Europe and Central Asia in 2020, compared with 170,000 in 2019, which experts attribute to a dramatic slowdown in screening, not a drop in cases. In 2020, for example, Romania managed to screen only 234,420 people for HIV/AIDS -- down nearly a third from 334,410 the previous year. It is a similar story in neighbouring Bulgaria. Regional health centres were "overwhelmed and hardly ever did any HIV testing during Covid," said Alexander Milanov, programme director at the country's National Patients' Organisation. The pandemic has disrupted supply chains and the transport of medicines, exacerbating historic shortages in countries such as Romania despite huge scientific strides that have dramatically improved outcomes for HIV patients in rich nations. Alexandru Tantu, a 28-year-old, HIV positive IT specialist, has seen first-hand how other European countries treat patients better, and how in Romania, it is a daily struggle to get the required drugs. "We came to realise that we are abandoned," he told AFP. "Hence all the anger and the fear that tomorrow we might not have our treatment." Still, with his stable job, he regards himself as relatively "privileged". In his advocacy work, he says, he receives calls from patients who are considering suicide. - 'Fear in the stomach' - The HIV/AIDS crisis in Romania dates back to the communist years. Around 11,000 children born in the 1980s under the communist regime of Nicolae Ceausescu were infected as a result of contaminated or unsterilised syringes or transfusions with untested blood. Today, several doctors told AFP that hospitals have yet to receive funds from the health ministry following a budgetary correction -- and in Romania, patients can only get the medication they need from hospitals, not pharmacies. Romania's health ministry did not respond to an AFP request for a comment. Volunteers do everything they can to fill the gaps in care. Alina Dumitriu and her "Sens Pozitiv" campaign group have been helping patients for 16 years, relying on donations. Between phone calls and texts from desperate patients, Dumitriu sorts out HIV pills, worth thousands of euros, from a red plastic bag. "There are months when I help up to 30 patients, while also sending some tablets to hospitals," she explains. "These patients still live with fear in their stomachs, not knowing if the next day they will still have medication," she says.
![]() ![]() Pfizer launches mRNA flu vaccine trial Washington (AFP) Sept 27, 2021 US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful Covid-19 shot. The idea is to improve on the current generation of flu vaccines that have an efficacy of 40-60 percent against a disease that can cause up to 650,000 deaths a year. "The Covid-19 pandemic allowed us to deliver on the immense scientific opportunity of mRNA," Kathrin Jansen, head of vaccine research at Pfizer, said in a ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |